Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 24724431 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | nevirapine | Japanese | carbamazepine | NA | unclassified | |
| NA | |||||||
| 32788606 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | skin rash | Korean | perampanel | NA | unclassified | |
| recently, antiepileptic drug-related adverse reactions, such as skin rash and even paes, have been discovered to be correlated with certain human leukocyte antigen (hla) types. | |||||||
| 33542445 | HLA-B*35 | nitazoxanide | NA | ivermectin | NA | unclassified | |
| Exanthema | |||||||
| 33542445 | HLA-B*35 | nitazoxanide | NA | ivermectin | NA | unclassified | |
| Hyperbilirubinemia | |||||||
| 33542445 | HLA-B*35 | nitazoxanide | NA | ivermectin | NA | unclassified | |
| Lipid Metabolism Disorders | |||||||
| 33542445 | HLA-DRB1*01 | nitazoxanide | NA | ivermectin | NA | unclassified | |
| Exanthema | |||||||
| 33542445 | HLA-DRB1*01 | nitazoxanide | NA | ivermectin | NA | unclassified | |
| Hyperbilirubinemia | |||||||
| 33542445 | HLA-DRB1*01 | nitazoxanide | NA | ivermectin | NA | unclassified | |
| Lipid Metabolism Disorders | |||||||
| 8199577 | HLA MATCHED (HLA-MATCHED) | polycythemia vera | NA | NA | NA | unclassified | |
| we present the case of an adolescent female with polycythemia vera, who was treated with a curative hla-matched allogeneic bone marrow transplant. | |||||||
| 8211001 | HLA (HLA) | small cell lung carcinoma | NA | chloroquine | NA | negation | |
| with the human small cell lung carcinoma h82, an optimal hla.a2 binding peptide (gilgfvftl) gave an upregulation response, whereas beta 2-m alone or in combination with this peptide had no effect. | |||||||
Copyright 2024